Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels

被引:34
作者
Anton, Ana I. [1 ]
Teruel, Raul [1 ]
Corral, Javier [1 ]
Minano, Antonia [1 ]
Martinez-Martinez, Irene [1 ]
Ordonez, Adriana [1 ]
Vicente, Vicente [1 ]
Sanchez-Vega, Beatriz [1 ]
机构
[1] Univ Murcia, Ctr Reg Hemodonac, Serv Hematol & Oncol Med HU Morales Meseguer, Murcia 30003, Spain
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷 / 04期
关键词
antithrombin; polymorphism; thrombotic risk; LENGTH POLYMORPHISM; III ACTIVITY; THROMBOSIS; GENE; DEFICIENCY; HEMOSTASIS; MUTATION; PROMOTER; DISEASE; REGION;
D O I
10.3324/haematol.2008.000604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Genetic factors involved in the interindividual variability of antithrombin have not been identified. We studied two polymorphisms of the gene coding for antithrombin (SERPINC1) in 298 Spanish Caucasian blood donors: rs3138521, a DNA length polymorphism located on the promoter region and rs2227589, a SNP located on intron 1 that has been described as a mild thrombotic risk factor. We detected a complete linkage disequilibrium between these polymorphisms (D'=0.999). The rs3138521 polymorphism has no functional consequences. However, the rs2227589 SNP significantly associated with plasma anti-FXa activity and antithrombin levels: carriers of the A allele had slightly but significantly lower anticoagulant activity and levels than GG subjects (97.0 +/- 7.3% vs. 94.6 +/- 8.4%; p=0.032; 99.5 +/- 5.8% vs. 94.8 +/- 5.6%; p=0.001; respectively). Our results identified a functional effect of the rs2227589 polymorphism not explained by its linkage with the promoter polymorphism that support the moderate thrombotic risk associated with the A allele.
引用
收藏
页码:589 / 592
页数:4
相关论文
共 19 条
[1]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[2]   Gene variants associated with deep vein thrombosis [J].
Bezemer, Irene D. ;
Bare, Lance A. ;
Doggen, Carine J. M. ;
Arellano, Andre R. ;
Tong, Carmen ;
Rowland, Charles M. ;
Catanese, Joseph ;
Young, Bradford A. ;
Reitsma, Pieter H. ;
Devlin, James J. ;
Rosendaal, Frits R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (11) :1306-1314
[3]  
Björk I, 1997, ADV EXP MED BIOL, V425, P17
[4]   CHARACTERIZATION OF AN UNUSUAL DNA LENGTH POLYMORPHISM-5' TO THE HUMAN ANTITHROMBIN-III GENE [J].
BOCK, SC ;
LEVITAN, DJ .
NUCLEIC ACIDS RESEARCH, 1983, 11 (24) :8569-8582
[5]  
CONLON MG, 1994, THROMB HAEMOSTASIS, V72, P551
[6]  
Corral J, 2005, HAEMATOLOGICA, V90, P238
[7]   INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA [J].
EGEBERG, O .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1965, 13 (3-4) :516-&
[8]   Interactions between genotype and phenotype in bleeding and thrombosis [J].
Franchini, Massimo ;
Mannucci, Pier Mannuccio .
HAEMATOLOGICA, 2008, 93 (05) :649-652
[9]   L-Asparaginase-induced antithrombin type I deficiency -: Implications for conformational diseases [J].
Hernandez-Espinosa, David ;
Minano, Antonia ;
Martinez, Constantino ;
Perez-Ceballos, Elena ;
Heras, Inmaculada ;
Fuster, Jose L. ;
Vicente, Vicente ;
Corral, Javier .
AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (01) :142-153
[10]   Complete antithrombin deficiency in mice results in embryonic lethality [J].
Ishiguro, K ;
Kojima, T ;
Kadomatsu, K ;
Nakayama, Y ;
Takagi, A ;
Suzuki, M ;
Takeda, N ;
Ito, M ;
Yamamoto, K ;
Matsushita, T ;
Kusugami, K ;
Muramatsu, T ;
Saito, H .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (07) :873-878